Clinical Trial Update: Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV) [Phase 2]

View source ↗

Summary

Phase II clinical trial results for SyB D-0701 in radiotherapy-induced nausea and vomiting have been completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiotherapy-induced Nausea and Vomiting

Drugs mentioned

• SyB D-0701

Snippet

Sponsor: SymBio Pharmaceuticals | Conditions: Radiotherapy-induced Nausea and Vomiting (RINV) | Phase 2 | Status: COMPLETED | Results posted: 2014-11-19